Estenzo, Rhea Mae .
HRN: 26-20-30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
CEFUROXIME 1.5GM (VIAL)
11/12/2024
11/13/2024
IV
1.5gm 3 Doses
Q8
Post Cs
Waiting Final Action
11/12/2024
CEFUROXIME 500MG (TAB)
11/13/2024
11/21/2024
PO
500mg
BID
Post Cs
Waiting Final Action
11/12/2024
METRONIDAZOLE 500MG (TAB)
11/13/2024
11/19/2024
PO
500mg
BID
Post C
Waiting Final Action